U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Method for inhibiting tumor growth rate using creatine or creatine analogs

Patent 5576316 Issued on November 19, 1996. Estimated Expiration Date: Icon_subject April 4, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Treatment of human tumors utilizing compounds having a phosphoamides linkage or enol phosphate linkage
Patent #: 5219846
Issued on: 06/15/1993
Inventor: Bru, et al.

Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated Patent #: 5324731
Issued on: 06/28/1994
Inventor: Kaddurah-Daouk, et al.

Inventor

Assignee

Application

No. 416499 filed on 04/04/1995

US Classes:

514/218, Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms514/275, Nitrogen bonded directly to the 1,3-diazine at 2-position by a single bond514/385, 1,3-diazoles514/386, Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent514/396, Imidazoles514/553, Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI514/561, Nitrogen other than as nitro or nitroso nonionically bonded514/563, RC(=O)N containing (i.e., carboxamide) (R is C or H)514/564, Plural nitrogens nonionically bonded514/579, Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI514/631, Amidines (i.e., N=C-N)514/638, Nitrogen double bonded directly to carbon514/646Benzene ring containing

Examiners

Primary: Nutter, Nathan M.

Attorney, Agent or Firm

International Classes

A61K 031/415
A61K 031/505
A01N 043/54
A01N 043/58

Abstract

A method for inhibiting tumor growth rate using creatine or creatine analogs is described. The creatine or creatine analogs are administered to subjects such that tumor growth rate is inhibited. Pharmaceutical compositions containing the creatine or creatine analogs and packaged products also are described.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?